Skull Base Tumors

  • Stefanie Milker-Zabel
  • Young Kwok
  • Jürgen Debus


The greatest challenge to neurosurgeons is tumors located at the skull base. In many patients, complete resection of skull base tumors is often not possible without a high risk of neurologic deficits and morbidity. Therefore, highly precise radiation techniques are required. For small tumor volumes, radiosurgery is often used. In case of large tumor volumes, fractionated stereotactic radiation therapy combines the advantage of spatial precision of radiosurgery and the radiobiological advantage of fractionation with better sparing of normal tissue [1].


Cranial Nerve Skull Base Radiat Oncol Biol Phys Gamma Knife Local Control Rate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Milker-Zabel S, Debus J, Thilmann C, et al. Fractionated stereotactically-guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001;50(5):1279–1286.PubMedGoogle Scholar
  2. 2.
    Debus J, Pirzkall A, Schlegel W, et al. Stereotaktische Einzeitbestrahlung (Radiochirurgie). Methodik, Indikationen, Ergebnisse. Strahlenther Onkol 1999;175:47–56.CrossRefPubMedGoogle Scholar
  3. 3.
    Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole brain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563–3569.PubMedGoogle Scholar
  4. 4.
    Neel HB, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma: review of 120 cases. Am J Surg 1973;126:547–556.CrossRefPubMedGoogle Scholar
  5. 5.
    Chandler JR, Goulding R, Moskowitz L, Quencer RM. Nasopharyngeal angiofibromas: staging and management. Ann Otol Rhinol Laryngol 1984;93:322–329.PubMedGoogle Scholar
  6. 6.
    Jafek BW, Krekorian EA, Kirsch WM, Wood RP. Juvenil nasopharyngeal angiofibroma: management of intracranial extension. Head and Neck Surg 1979;2(2):119–128.CrossRefGoogle Scholar
  7. 7.
    Jacobsson M, Petruson B, Svendsen P, et al. Juvenil nasopharyngeal angiofibroma: a report of eighteen cases. Acta Otolaryngol (Stockh) 1988;105:132–139.CrossRefGoogle Scholar
  8. 8.
    Kuppersmith RB, The BS, Donovan DT, et al. The use of intensity-modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Othorhinolaryngol 2000;52(3):261–268.CrossRefGoogle Scholar
  9. 9.
    Dare AO, Gibbons KJ, Proulx GM, Fenstermaker RA. Resection followed by radiosurgery for advanced juvenile nasopharyngeal angiofibroma: report of two cases. Neurosurgery 2003;52:1207–1211.CrossRefPubMedGoogle Scholar
  10. 10.
    McGahan RA, Durrance FY, Parke RB Jr, et al. The treatment of advanced juvenile nasopharyngeal angiofibroma. Int J Radiat Oncol Biol Phys. 1989;17(5):1067–1072.PubMedGoogle Scholar
  11. 11.
    Briant TD, Fitzpatrick PJ, Berman J. Nasopharyngeal angiofibroma: a twenty year study. Laryngoscope 1978;88:1247–1251.CrossRefPubMedGoogle Scholar
  12. 12.
    Cummings BJ, Blend R, Keane T, et al. Primary radiation therapy for juvenile nasopharyngeal angiofibroma. Laryngoscope 1984;94:1599–1605.CrossRefPubMedGoogle Scholar
  13. 13.
    Reddy KA, Mendenhall WM, Amdur RJ, et al. Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 2001;22:172–175.CrossRefPubMedGoogle Scholar
  14. 14.
    Wiatrak BJ, Koopmann CF, Turrisi AT. Radiation therapy as an alternative to surgery in the management of intracranial juvenile nasopharyngeal angiofibroma. Int J Pediatr Othorhinolaryngol 1993;28:51–61.CrossRefGoogle Scholar
  15. 15.
    Takeda A, Shigematsu N, Susuki S, et al. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose and severity. Int J Radiat Oncol Biol Phys 1999;4:599–605.CrossRefGoogle Scholar
  16. 16.
    Berger L, Luc R. L’esthésioneuroépithéliome olfactif. Bull Assoc Fr Etude Cancer 1924;13:410–421.Google Scholar
  17. 17.
    Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976;37:1572–1576.Google Scholar
  18. 18.
    Wieden PL, Yarington CT Jr, Richardson RG. Olfactory neuroblastoma: chemotherapy and radiotherapy for extensive disease. Arch Otolaryngol 1984;110:759–760.Google Scholar
  19. 19.
    Dulguerov P, Calcaterre T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992;102:843–849.CrossRefPubMedGoogle Scholar
  20. 20.
    Kempf H-G, Becker G, Weber BP, Ruck P. Diagnostik und Therapie des Olfaktoriusneuroblastoms. HNO 1994;42:422–428.PubMedGoogle Scholar
  21. 21.
    Zabel A, Thilmann C, Milker-Zabel S, et al. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol 2002;178(4):187–191.CrossRefPubMedGoogle Scholar
  22. 22.
    Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706–715.PubMedCrossRefGoogle Scholar
  23. 23.
    Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998;42:1029–1037.CrossRefPubMedGoogle Scholar
  24. 24.
    Unger F, Haselsberger K, Walch C, Stammberger H, Papaefthymiou G. Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien) 2005;147(6):595–601.CrossRefGoogle Scholar
  25. 25.
    Leber KA, Berglöff J, Pendl G. Dose-response tolerance of the visual pathwaya and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998;88:43–50.CrossRefPubMedGoogle Scholar
  26. 26.
    Ling SM, Linzer D, Lu J, et al. Local control of large primary brain tumours or metastasis treated by Leksell Gamma Knife stereotactic radiosurgery: an analysis of dose-volume considerations, local control and complications. J Radiosurg 1999;2:141–152.CrossRefGoogle Scholar
  27. 27.
    Chao KSC, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001;23:749–757.CrossRefPubMedGoogle Scholar
  28. 28.
    Walch C, Stammberger H, Anderhuber W, Unger F, Köle W, Feichtinger K. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000;110:635–640.CrossRefPubMedGoogle Scholar
  29. 29.
    Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurol Clin 1991;9:453–465.PubMedGoogle Scholar
  30. 30.
    Rutka JT, Hoffman HR, Drake JM, et al. Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin North Am 1992;3:803–820.Google Scholar
  31. 31.
    Fisher PG, Jenab J, Gopldthwaite PT, et al. Outcomes and failure patterns in childhood craniopharyngeomas. Childs Nerv Syst 1998;14:558–563.CrossRefPubMedGoogle Scholar
  32. 32.
    Abrams LS, Repka MX. Visual outcome of craniopharyngeoma in children. J Pediatr Ophthalmol Strabis 1997;34:223–228.Google Scholar
  33. 33.
    Lewis D. A contribution to the subject of tumors of the hypophysis. JAMA 1910;55:1002–1008.Google Scholar
  34. 34.
    Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999;90:237–250.CrossRefPubMedGoogle Scholar
  35. 35.
    Samii M, Bini W. Surgical treatment of craniopharyngiomas. Zentralblatt Neurochir. 1991;52:17–23.Google Scholar
  36. 36.
    Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 1990;73:3–11.CrossRefPubMedGoogle Scholar
  37. 37.
    Kalapurakal JA, Goldman S, Hsieh YC, et al. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J 2000;6(6):388–393.PubMedGoogle Scholar
  38. 38.
    Hoffmann HJ, DeSilva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngioma in children. J Neurosurg 1992;76:47–52.CrossRefGoogle Scholar
  39. 39.
    Becker G, Kortmann RD, Skalej M, Bamberg M. The role of radiotherapy in the treatment of craniopharyngiomas—indications, results, side effects. Front Radiat Ther Oncol 1999;33:100–113.CrossRefPubMedGoogle Scholar
  40. 40.
    Jose CC, Rajan B, Ashley S, et al. Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol 1992;4:287–289.CrossRefGoogle Scholar
  41. 41.
    Sanford RA. Craniopharyngioma: results of survey of the American Society of pediatric Neurosurgery. Pediatr Neurosurg 1994;21(Suppl 1):39–43.CrossRefPubMedGoogle Scholar
  42. 42.
    Rajan B, Ashley S, Gorman C, et al. Craniopharyngioma—long-term results following limited surgery and radiotherapy. Radiother Oncol 1993;26:1–10.CrossRefPubMedGoogle Scholar
  43. 43.
    Chung WY, Pan DH, Shiau CY, et al. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 2000;93(Suppl 3):47–56.PubMedGoogle Scholar
  44. 44.
    Sung DI, Chang CH, Harisiadis L, et al. Treatment results of craniopharyngiomas. Cancer 1981;47:847–852.CrossRefGoogle Scholar
  45. 45.
    Fischer EG, Welch K, Shillito J Jr, et al. Craniopharyngiomas in children: Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 1990;73:534–540.CrossRefPubMedGoogle Scholar
  46. 46.
    Mokry M. Craniopharyngiomas: a six year experience with Gamma Knife radiosurgery. Stereotact Funct Neurosurg 1999;72(Suppl 1):140–149.CrossRefPubMedGoogle Scholar
  47. 47.
    Voges J, Sturm V, Lehrke R, et al. Cystic craniopharyngiomas: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 1997;35:1001–1010.Google Scholar
  48. 48.
    Ülfarsson E, Lindquist C, Roberts M, et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 2002;97(Suppl 5):613–622.PubMedGoogle Scholar
  49. 49.
    Schulz-Ertner D, Frank C, Herfarth KK, et al. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 2002;54:1114–1120.CrossRefPubMedGoogle Scholar
  50. 50.
    Kobayashi T, Kida Y, Mori Y, et al. Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg 2005;103(6 Suppl):482–488.PubMedGoogle Scholar
  51. 51.
    Al Mefty O, Borba LA. Skull base chordomas: a management challenge. J Neurosurg 1997;86:182–189.CrossRefGoogle Scholar
  52. 52.
    Gay E, Sekhar LN, Rubinstein E, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995;36:887–896.CrossRefPubMedGoogle Scholar
  53. 53.
    Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91:432–439.CrossRefPubMedGoogle Scholar
  54. 54.
    Kondziolka D, Lunsford LD, Flickinger JC. The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery 1991;29:38–45.CrossRefPubMedGoogle Scholar
  55. 55.
    Pearlman AW, Friedman M. Radical radiation therapy of chordoma. AJR 1970;108:332–341.Google Scholar
  56. 56.
    Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl II):57–63.CrossRefPubMedGoogle Scholar
  57. 57.
    Schulz-Ertner D, Nikoghosyan A, Thilman C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004;58(2):631–640.PubMedGoogle Scholar
  58. 58.
    Noel G, Habrand JL, Mammar H, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre of Protontherapie D’Orsay experience. Int J Radiat Oncol Biol Phys 2001;51:392–398.PubMedGoogle Scholar
  59. 59.
    Debus J, Haberer T, Schulz-Ertner D, et al. Fractionated carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther Oncol 2000;176(5):211–216.CrossRefGoogle Scholar
  60. 60.
    Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Carbon ion radiotherapy for chordomas and low grade chondrosarcomas of the skull base. Results in 67 patients. Strahlenher Onkol 2003;179(9):598–605.CrossRefGoogle Scholar
  61. 61.
    Feigl GC, Bundschuh O, Gharabaghi A, et al. Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas. J Neurosurg 2005;102(Suppl):154–170.Google Scholar
  62. 62.
    Pamir MN, Kilic T, Türe U, Özek MM. Multimodality management of 26 skull base chordomas with 4-year mean follow-up: experience at a single institution. Acta Neurochir (Wien) 2004;146:343–354.CrossRefGoogle Scholar
  63. 63.
    Berson AM, Castro JR, Petti P, et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: The Lawrence Berkely Laboratory experience. Int J Radiat Oncol Biol Phys 1988;15:559–565.PubMedGoogle Scholar
  64. 64.
    Krishnan S, Foote R, Brown P, et al. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery 2005;56(4):777–784;discussion 777-784.CrossRefPubMedGoogle Scholar
  65. 65.
    Chang SD, Martin DP, Lee E, et al. Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for residual or recurrent cranial base and cervical chordomas. Neurosurg Focus 2001;10(3):E5.CrossRefPubMedGoogle Scholar
  66. 66.
    Konefal JB, Pilepich MV, Spector GJH, et al. Radiation therapy in the treatment of chemodectomas. Laryngoscope 1987;97:1331–1335.CrossRefPubMedGoogle Scholar
  67. 67.
    Foote RL, Coffey RJ, Gorman DA, et al. Stereotactic radiosurgery for glomus jugulare tumors: a preliminary report. Int J Radiat Oncol Biol Phys 1997;38:491–495.PubMedGoogle Scholar
  68. 68.
    Saringer W, Khayal H, Ertl A, et al. Efficiency of gamma knife radiosurgery in the treatment of glomus jugulare tumors. Minim Invas Neurosurg 2001;44:141–145.CrossRefGoogle Scholar
  69. 69.
    Woods CI, Strasnick B, Jackson CG. Surgery for glomus tumors: the otology group experience. Laryngoscope 1993;60(Suppl):65–70.Google Scholar
  70. 70.
    Pauw BK, Malek MS, Fisch U, Valvanis A. Preoperative embolization of paragangliomas (glomus tumors) of the head and neck; histopathologic and clinical features. Skull Base Surgery 1993;3:37–44.CrossRefPubMedGoogle Scholar
  71. 71.
    Chretien PB, Engelman K, Hoye RC, Geelhoed GW. Surgical management of intravascular glomus jugulare tumors. Am J Surg 1971;122740–122743.Google Scholar
  72. 72.
    Jordan JA, Roland PS, McManus C, et al. Stereotactic radiosurgery for glomus jugulare tumors. Laryngoscope 2000;110:35–38.CrossRefPubMedGoogle Scholar
  73. 73.
    Lim M, Gibbs IC, Adler JR, et al. The efficacy of linear accelerator stereotactic radiosugery in treating glomus jugulare tumors. Technol Cancer Res Treatm 2003;2(3):261–265.Google Scholar
  74. 74.
    Maarouf M, Voges J, Landwehr P, et al. Stereotactic linear accelerator-based radiosurgery for the treatment of patients with glomus jugulare tumors. Cancer 2003;97:1093–1098.CrossRefPubMedGoogle Scholar
  75. 75.
    Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumors: tumor control and complications after stereotactic radiosurgery. Head Neck 2002;24:332–339.CrossRefPubMedGoogle Scholar
  76. 76.
    Eustacchio S, Trummer M, Unger F, et al. The role of Gamma Knife radiosurgery in the management of glomus jugular tumours. Acta Neurochir Suppl 2002;84:91–97.PubMedGoogle Scholar
  77. 77.
    Maarouf M, Voges J, Landwehr P, et al. Stereotactic linear accelerater-based radiosurgery for the treatment of patients with glomus jugulare tumors. Cancer 2003;97(4):1093–1098.CrossRefPubMedGoogle Scholar
  78. 78.
    Liscak R, Vladyka V, Wowra B, et al. Gamma Knife radiosurgery of the glomus jugulare tumour — early multicentre experience. Acta Neurochir (Wien) 1999;141(11):1141–1146.CrossRefGoogle Scholar
  79. 79.
    Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004;17(2):E4.CrossRefPubMedGoogle Scholar
  80. 80.
    Mukherji SK, Kasper ME, Tart RP, Mancuso AA. Irradiated paragangliomas of the head and neck: CT and MR appearance. AJNR Am J Neuroradiol 1994;15(2):357–3363.PubMedGoogle Scholar
  81. 81.
    Zabel A, Thilmann C, Zuna I, et al. Comparison of forward planned conformal radiation therapy and inverse planed intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 2002;75:356–361.PubMedGoogle Scholar
  82. 82.
    Zabel A, Milker-Zabel S, Huber P, et al. Fractionated stereotactic conformal radiotherapy of chemodectomas of the skull base. Int J Radiat Oncol Biol Phys 2004;58:1445–1450.CrossRefPubMedGoogle Scholar
  83. 83.
    Milker-Zabel S, Zabel A, Schulz-Ertner D, et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningiomas—long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61(3):810–817.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Stefanie Milker-Zabel
    • 1
  • Young Kwok
    • 2
  • Jürgen Debus
    • 3
  1. 1.Departments of Radiation Oncology and Radiation TherapyHospital of HeidelbergHeidelbergGermany
  2. 2.Department of Radiation OncologyUniversity of Maryland Medical CenterBaltimoreUSA
  3. 3.Department of Radiation Oncology and Radiation TherapyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations